The Series A round was led by Exor Ventures with backing from various angel investors to support product development and international growth.
"We’ve dedicated ourselves to building products that white-collar professionals deeply value for corporate structuring. Up next, we’re going to double down on generative AI and collaboration features. We also plan to expand our multi-product line focused on visualising complex transactions into an end-to-end platform to manage corporate structures and governance."
The investment round was led by existing backers including Sony Innovation Fund.
"We have built a great relationship with our investors, who fully back our mission of using technology to make insurance fairer, and doing so in a sustainable way."
The Series A round was led by AlbionVC just seven months after the company secured its pre-seed financing.
"Since our launch in September, the demand for instant, comprehensive insights across various nature-based data domains has exceeded our expectations. Treefera meets this demand by providing real-time transparency and accuracy, crucial for businesses navigating environmental challenges and supply chain complexities."
Wealth Club, EHE Capital and Angels Invest Wales backed the oversubscribed raise to support product development and international demand.
"The insurance industry has barely changed since insurance started being sold online thirty years ago. Technology, specifically AI, has the potential to completely change the way consumers buy and manage their insurance policies and can also deliver significant benefits to providers at the same time."
Par Equity led the follow-on investment round, backed by Thairm Bio and Scottish Enterprise, to support nationwide scaling.
"In the UK tech sector, the investment climate has been both unpredictable and incredibly challenging for the past two years. Despite this, Phlo’s investors have provided the leadership team with a huge vote of confidence in our business model and product ecosystem. This gives additional significance to the close of this fresh investment round, which will unlock huge business and growth opportunities across the entire Phlo network. I’d like to thank Par Equity, Thairm Bio and Scottish Enterprise for their support and belief in Phlo’s vision for the future of healthcare."
.png)
